Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS- and BRAF-mutant cancer cells | Science Signaling
Loss of a protein phosphatase drives resistance to MAPK pathway inhibition in KRAS- and BRAF-mutant cancer cells.